Caring Brands, Inc.

Caring Brands, Inc. is a Nevada-based wellness consumer products company focused on over-the-counter and prescription-grade health and cosmetic products. Its reported pipeline includes hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, and a jellyfish-sting protective suncare line. The company emphasizes product development around established mechanisms of action, clinical evidence, patent protection, and commercial stability. It is still in an early commercialization stage and has reported inconsequential revenue to date, with management noting that the business is still being developed.

−133 689,8 %

55,6 %

−148 948,8 %

13.16

13.09

— Caring Brands, Inc.
%
Hair and scalp care25% Products aimed at hair loss treatment and related scalp wellness needs.
Dermatology and skin condition treatments45% OTC and prescription-grade products for eczema, psoriasis, and vitiligo.
Protective suncare20% Specialty suncare products designed to help protect against jellyfish stings.
Other wellness products10% Additional consumer health and cosmetic products in development or early commercialization.

Caring Brands sells directly to end users, so its customers are individual consumers rather than institutional buyers...

  • Direct-to-consumer end usersprimary

    Individuals purchase products directly for personal use, attracted by condition-specific benefits and convenience.

  • Hair loss treatment consumerssecondary

    Buyers seeking hair loss solutions with a credible mechanism of action and visible cosmetic outcomes.

  • Dermatology and skin-condition usersprimary

    Consumers with eczema, psoriasis, or vitiligo who need targeted OTC or prescription-grade products.

  • Specialty suncare buyersemerging

    Consumers needing protective suncare products for specific environmental exposure, including jellyfish-sting protection.

The company has not disclosed meaningful geographic revenue diversification and states that it does not currently...

  • •United States is the company’s home market and corporate base
  • •No meaningful geographic revenue diversification has been disclosed
  • •Revenue is not currently disaggregated by geography or channel
  • •Early-stage commercialization limits current international exposure
  • •Future growth may depend on expanding beyond the initial U.S. base

Caring Brands’ strategy is centered on building a portfolio of differentiated wellness products with a clear mechanism...

01
Advance product pipeline through clinical validationshort-term

Clinical evidence is central to the company’s positioning and supports consumer trust, regulatory credibility, and commercialization.

02
Protect intellectual propertymedium-term

Patent protection can help defend niche formulations and improve the durability of any future revenue streams.

03
Build commercialization capability and capital baseshort-term

The company is still early-stage and needs funding, operating discipline, and market access to convert the pipeline into sales.

The most immediate risk is that Caring Brands is still an early-stage company with no meaningful operating history and...

critical

Going-concern uncertainty

The company states it was recently formed, has no operations, and may not have sufficient resources to execute its business plan.

Scope
Corporate funding and continuity of operations
Materiality
high
high

Commercialization failure

Pipeline products may not achieve market acceptance even if development work is completed.

Scope
Revenue generation from new products
Materiality
high
high

Clinical and product-claims risk

The company’s strategy depends on established mechanism of action and controlled clinical trials to support efficacy claims.

Scope
Product development and marketing claims
Materiality
high
medium

Intellectual property risk

The company relies on issued and filed patents to protect differentiation in niche wellness products.

Scope
Pipeline protection and competitive moat
Materiality
medium
ASC 606 revenue recognition at shipment
Can shift revenue between periods
Going-concern assessment
Affects liquidity analysis and valuation assumptions
Estimates and judgments
Can affect expense accruals and balance sheet estimates

PERRIGO Co plc

PRGO · Pharmaceutical Preparations

Kenvue Inc.

KVUE · Perfumes, Cosmetics & Other Toilet Preparations

Functional Brands Inc.

MEHA · Medicinal Chemicals & Botanical Products

Prestige Consumer Healthcare Inc.

PBH · Pharmaceutical Preparations

Hi-Great Group Holding Co

HIGR · Hotels & Motels

Kairos Pharma, LTD.

KAPA · Pharmaceutical Preparations

: 28/04/2026